News

The Biden Administration is previewing its next step in regaining American leadership in the pharmaceutical industry after focusing on the country's supply chains for pharmaceuticals last winter. On September 12th, President Joe Biden signed an executive order to advance...

The history of the medical field is a fascinating one. When the slightest thing can mean life or death in this field, looking back at how wrong the brightest minds of the world initially were makes for tense reading....

Once you discover that you or your partner has pearly penile papules, it’s easy to feel like it’s the end of the world—this feeling has its roots in the fact that you have little to no knowledge about it....

The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities and capacity for early technological development of biologics, the multi-year investment will be deployed...

In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat, better known as TPOXX. The study's researchers hope to include more than 500 participants from...

Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker is giving an early peek at the precise data that might set the benchmark for...

The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical Trials in the EU (ACT EU). Building on the Clinical Trials Regulation (CTR) and Clinical Trials...